EVENTS:   Best Equity Short Ideas Conference Call 12 - Zach Shannon/Corto Capital Advisors & Craig Huber/Huber Research Partners & Thomas Beevers /Forensic Alpha & Ed Steele/Iron Blue Financials & Bill Campbell/Paragon Intel - 12 Nov 25   Will AI Deflate the World? Macro Lessons from Three Industrial Revolutions and China - Manoj Pradhan/Talking Heads Macro - 13 Nov 25     ROADSHOWS: Forest Products Sector Equity and Commodity Research With Expertise in Distressed Debt - Kevin Mason /ERA Research   •   London   12 - 14 Nov 25       Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech - Andrew Peters /Revelare Partners   •   London   17 - 19 Nov 25       Fundamental US Healthcare Short Ideas - Dr Elliot Favus /Favus Institutional Research   •   London   17 - 19 Nov 25      

Fortnightly Publication Highlighting Latest Insights From IRF Providers

Company Research

Raia Drogasil (RADL3 BZ)

Consumer Staples

MYST Advisors

The Brazilian pharmaceutical market has grown at a ~12% CAGR “forever”, with only one down month going back 20+ years (Apr 20 when ALL stores were closed). RD has consistently gained ~50bps of market share every year since 2007 and is bigger than the #2 through #5 players combined. The presenter highlighting the stock at MYST’s Consumer Event envisions considerable upside to earnings, underscoring management’s “phenomenal” track record, “incredible” unit economics with ~35% ROIs on new stores, and while current EBIT margins are ~5%, mature stores are yielding closer to LDD’s. TP R$48 (70% upside).

Edition: 161

- 26 May, 2023